ArticleEmerging infectious diseases2013
Coccidioidomycosis-associated hospitalizations, California, USA, 2000-2011.
Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Talaromyces marneffei, Coccidioides species, and Paracoccidioides species-a systematic review to inform the World Health Organization priority list of fungal pathogens.Medical mycology · 2024Pooled it
- Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Article
- Estimating the Exposure-Response Relationship between Fine Mineral Dust Concentration and Coccidioidomycosis Incidence Using Speciated Particulate Matter Data: A Longitudinal Surveillance Study.Environmental health perspectives · 2025Article
- Article
- Relapse of Pediatric Coccidioidomycosis Tenosynovitis.Journal of hand surgery global online · 2023Article
- Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2022Review
- Pulmonary Coccidioidomycosis: A Case Report and Literature Review.Medicina (Kaunas, Lithuania) · 2022Review
- Sex Differences in Susceptibility to Coccidioidomycosis.Open forum infectious diseases · 2022Article
- Multi-Scale Airborne Infectious Disease Transmission.Applied and environmental microbiology · 2021Review
- Economic Valuation of Coccidioidomycosis (Valley Fever) Projections in the United States in Response to Climate Change.Weather, climate, and society (Print) · 2021Article
- Sociodemographic factors associated with patients hospitalised for coccidioidomycosis in California and Arizona, State Inpatient Database 2005-2011.Epidemiology and infection · 2020Article
- Valley Fever: Environmental Risk Factors and Exposure Pathways Deduced from Field Measurements in California.International journal of environmental research and public health · 2020Article
- Risk for Coccidioidomycosis among Hispanic Farm Workers, California, USA, 2018.Emerging infectious diseases · 2020Article
- Article
- Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change.GeoHealth · 2019Article
- Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.Current tropical medicine reports · 2019Article
- The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California.International journal of environmental research and public health · 2019Article
- Coccidioidomycosis Among American Indians and Alaska Natives, 2001-2014.Open forum infectious diseases · 2019Article
- Valley Fever on the Rise-Searching for Microbial Antagonists to the Fungal PathogenMicroorganisms · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In the past decade, state-specific increases in the number of reported cases of coccidioidomycosis have been observed in areas of California and Arizona where the disease is endemic. Although most coccidioidomycosis is asymptomatic or mild, infection can lead to severe pulmonary or disseminated disease requiring hospitalization and costly disease management. To determine the epidemiology of cases and toll of coccidioidomycosis-associated hospitalizations in California, we reviewed hospital discharge data for 2000-2011. During this period, there were 25,217 coccidioidomycosis-associated hospitalizations for 15,747 patients and >$2 billion US in total hospital charges. Annual initial hospitalization rates increased from 2.3 initial hospitalizations/100,000 population in 2000 to 5.0 initial hospitalizations/100,000 population in 2011. During this period, initial hospitalization rates were higher for men than women, African Americans and Hispanics than Whites, and older persons than younger persons. In California, the increasing health- and cost-related effects of coccidioidomycosis-associated hospitalizations are a major public health challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.